Articles From: CVS Caremark Reports Record Second Quarter Results to Cyan to Participate in J.P. Morgan SDN Forum


WOONSOCKET, R.I. , Aug.
Sign-up for CVS Caremark Reports Record Second Quarter Results investment picks
WOONSOCKET, R.I. , Aug.
Sign-up for CVS Caremark To Present At The Morgan Stanley 2014 Global Healthcare Conference investment picks
WOONSOCKET, R.I. , Aug.
Sign-up for CVS Caremark's Accordant Health Services Receives NCQA Disease Management Accreditation investment picks
NEW YORK (MarketWatch) -- Shares of CVS Caremark Corp.
Sign-up for CVS climbs after beating earnings forecasts, lifting outlook investment picks
Clinical collaboration with CVS/pharmacy and MinuteClinic will increase access to care and help improve medication adherence for patients WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Announces New Clinical Affiliations with Leading Academic Medical Centers investment picks
Address to also highlight innovations aimed at reducing epidemic of chronic disease in America and delivering better health outcomes for consumers WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation investment picks
Largest Hispanic-owned drugstore chain in the U.S. will keep Navarro name Combination of Navarro and CVS/pharmacy will strengthen service to Hispanic community WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Completes Purchase of Navarro Discount Pharmacy investment picks
WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Corporation Announces Final Results of Tender Offers investment picks
WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Corporation Announces Quarterly Dividend investment picks
2014/10/2
Company focused on increasing adherence by five to 15 percent through new interventions by 2017 WOONSOCKET, R.I. , Oct.
Sign-up for CVS Health Insights Report Tackles Complex Issue of Medication Adherence investment picks
Data published in The American Journal of Managed Care based on quality of care measures from RAND and professional medical organizations MinuteClinic care for common acute conditions same or better than Emergency Departments and Ambulatory Care Facilities WOONSOCKET, R.I. , Oct.
Sign-up for CVS Health Research Institute Data Shows Excellent Quality of Care at MinuteClinic for Common Acute Conditions investment picks
CVS Health sponsors October Issue of Health Affairs featuring articles focused on specialty pharmacy WOONSOCKET, R.I. , Oct.
Sign-up for CVS Health Research Institute Examines Tools to Slow Dramatic Cost Growth of Specialty Drugs investment picks
2014/9/17
Data shows recent plateau and drop in therapy utilization, but experts suggest new surge upon pending approval of new regimens Therapy discontinuation rates were nearly four times higher than in clinical trials, pointing to importance of focusing on medication adherence strategies CVS/Caremark specialty pharmacy support results in higher rates of medication adherence for patients undergoing therapy WOONSOCKET, R.I. , Sept.
Sign-up for CVS Health Research Institute Provides First Look at Treatment with New Hepatitis C Therapies investment picks
Patients starting on generic statins vs.
Sign-up for CVS Health Research Institute Study is First to Show Improved Medication Adherence and Health Outcomes for Generic Statins investment picks
2014/10/1
WOONSOCKET, R.I. , Oct.
Sign-up for CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health investment picks
By Paul Ziobro CVS Caremark Corp.
Sign-up for CVS renames itself CVS Health investment picks
2014/8/15
Flu vaccinations available at CVS/pharmacy and MinuteClinic, including high dose flu shot for senior population Flu vaccine is a preventive service under the Affordable Care Act, fully covered and available at no cost through most insurance plans WOONSOCKET, R.I. , Aug.
Sign-up for CVS/pharmacy Consumer Survey Finds Three in Five Americans are Unaware of the Importance of the High Dose Flu Vaccine in Senior Flu Prevention investment picks
2014/7/31
URAC's new accreditation validates the quality of CVS/pharmacy's patient care WOONSOCKET, R.I. and WASHINGTON , July 31, 2014 /PRNewswire/ -- CVS/pharmacy and URAC announced today that CVS/pharmacy is the first pharmacy in the nation to earn the new Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry.
Sign-up for CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC investment picks
2014/8/11
New store in Renton, WA marks CVS/pharmacy's entrance into Seattle market WOONSOCKET, R.I. , Aug.
Sign-up for CVS/pharmacy Opens its First Pharmacy in Washington State investment picks
2014/9/25
Donation program accepting new applications for police departments nationwide to receive drug collection units Nearly 200 drug collection events to take place at CVS/pharmacy this Saturday WOONSOCKET, R.I. , Sept.
Sign-up for CVS/pharmacy Renews Drug Collection Program in Recognition of National Prescription Drug Take Back Day investment picks
Patients can receive personalized plan comparisons in-store or online to find a Medicare plan that meets their individual needs CVS/pharmacy participating in several Medicare Part D preferred pharmacy networks with no or low co-pays on generic prescriptions WOONSOCKET, R.I. , Oct.
Sign-up for CVS/pharmacy to Help Patients Save Time and Money During Annual Medicare Part D Enrollment Period investment picks
2014/8/7
Premium Beauty Line Launches Exclusively at CVS/pharmacy Locations Nationwide WOONSOCKET, R.I. , Aug.
Sign-up for CVS/pharmacy® Introduces Pro-Designed Makeup Academy Collection investment picks
CWT Meetings & Events, the award-winning meetings and events agency, today announced it has strengthened its overall client technology offering by signing an agreement with Cvent, Inc .
Sign-up for CWT Meetings & Events Signs Agreement with Cvent investment picks
Cyan (NYSE: CYNI) , a leading provider of SDN, NFV, and packet-optical solutions for network operators, today announced that it will release its financial results for its third quarter ended September 30, 2014 before the U.S. markets open on Thursday, November 6, 2014.
Sign-up for Cyan Announces Third Quarter 2014 Financial Results Conference Call investment picks
Cyan (NYSE: CYNI), a leading provider of SDN, NFV, and packet-optical solutions for network operators, today announced a series of new features to its Cyan Z-Series Packet-Optical Transport (P-OTP) and Blue Planet SDN platforms.
Sign-up for Cyan Extends Packet-Optical Leadership & Drives Network Transformation Vision Forward with Major Enhancements investment picks
Cyan (NYSE: CYNI), a leading provider of SDN, NFV, and packet-optical solutions for network operators, today announced financial results for its second quarter ended June 30, 2014.
Sign-up for Cyan Reports Second Quarter 2014 Financial Results investment picks
Cyan (NYSE:CYNI), a leading provider of SDN, NFV, and packet-optical solutions for network operators, today announced support for Cisco ASR 901, ASR 903, ASR 9000 and ME 3600 platforms, as well as the Juniper MX960, MX480, and MX2010 platforms in Cyan’s Blue Planet SDN Platform.
Sign-up for Cyan Significantly Expands Addressable Market with Blue Planet Support for Cisco ASR and Juniper MX Platforms investment picks
Cyan (NYSE: CYNI), a leading provider of SDN, NFV, and packet-optical solutions for network operators, today announced that management will attend the following upcoming financial event: About Cyan Cyan (NYSE: CYNI) enables network transformation.
Sign-up for Cyan to Attend Upcoming Financial Event investment picks
Cyan (NYSE:CYNI), a leading provider of SDN, NFV, and packet-optical solutions for network operators, today announced that management will attend the following upcoming financial event: About Cyan Cyan (NYSE: CYNI) enables network transformation.
Sign-up for Cyan to Participate in J.P. Morgan SDN Forum investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: CVS Caremark Reports Record Second Quarter Results to Cyan to Participate in J.P. Morgan SDN Forum
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices